Trademark: 90538254
Word
LYBALVI
Status
Dead
Status Code
601
Status Date
Wednesday, July 28, 2021
Serial Number
90538254
Mark Type
4000
Filing Date
Monday, February 22, 2021
Abandoned Date
Tuesday, July 27, 2021
Trademark Owner History
Alkermes Pharma Ireland Limited
Classifications
5 Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia
Trademark Events
Jul 28, 2021
Abandonment Notice E-Mailed - Express Abandonment
Jul 28, 2021
Abandonment - Express Mailed
Jul 27, 2021
Teas Express Abandonment Received
Jul 26, 2021
Notification Of Non-Final Action E-Mailed
Jul 26, 2021
Non-Final Action E-Mailed
Jul 26, 2021
Non-Final Action Written
Jul 23, 2021
Notice Of Reinstatement E-Mailed
Jul 22, 2021
Reinstatement Granted - Inadvertently Abandoned
Jul 22, 2021
Abandonment - Express Mailed
Jul 22, 2021
Assigned To Examiner
May 22, 2021
New Application Office Supplied Data Entered In Tram
Feb 25, 2021
New Application Entered In Tram
ACTIVATE
BUDDYLINK
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov